Caribou is scaling back its operations, halting multiple programmes, and cutting staff to focus on two cancer programmes.

In the contemporary landscape of science and technology, the exploration of advanced functional materials is gaining ...

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.

"Moreover, the duration of follow-up is among the longest reported for a lentiviral vector-based gene therapy; 13 patients ...

Caribou Biosciences is paring down its pipeline and cutting about a third of its workforce as cell and gene therapy companies ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

If administered early, gene therapy has the potential to change the medical history of children born with metachromatic ...

Hathway’s technology uses natural epigenetic processes to dial gene activity up or down, rather than rewriting the genetic ...

A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for ...

The role of insects in drug discovery is expanding, with biopharmaceuticals derived from insect cells offering sustainable solutions for medical applications.